Delivery Order SPE2DR25D1017-SPE2DR26F9ECU
Award Date 1/30/26
Potential Completion Date 2/2/26
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $16,007.47 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, valued at $1,041.42. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4,430.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract, with an ultimate completion date of January 29, 2026, represents a child order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. This delivery order was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $8,826.84 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of September 4, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will...
- The Defense Logistics Agency awarded a $5,473.29 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 MG/ML SureClick auto-injector units, with a completion date of December 1, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol, representing the type of specialized pharmaceutical product that...
- The Defense Logistics Agency awarded a $13,134.83 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors on January 28, 2026, with an ultimate completion date of January 29, 2026. This firm fixed-price, non-set-aside contract is performed at the awardee's corporate office in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $11,808.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 10, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. REPATHA is a prescription medication used to treat high cholesterol, and...
- The Defense Logistics Agency awarded a $17,662.41 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of November 12, 2025. This non-competitive delivery order was issued on November 10, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to treat high cholesterol and reduce cardiovascular risk in eligible...
- The Defense Logistics Agency awarded a $3,491.63 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injector medication on January 16, 2026, with completion targeted for January 20, 2026. This is a firm fixed-price contract with no set-aside designation, awarded competitively to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's parent company Cencora,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,214.99 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. REPATHA is a prescription medication used to lower cholesterol levels and...